Reaction
Dermatillomania reporting signals
As of the last recalculation, Dermatillomania appears in 576 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is LISDEXAMFETAMINE DIMESYLATE (PRR 77.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lisdexamfetamine Dimesylate | 63 | 77.3 | 77.5 |
| Aripiprazole | 142 | 55.3 | 55.3 |
| Acetylcysteine | 11 | 43.0 | 43.0 |
| Aripiprazole Oral | 44 | 41.5 | 41.6 |
| Aripiprazole Orally Disintegrating | 44 | 41.5 | 41.6 |
| Guanfacine | 7 | 32.5 | 32.6 |
| Methylphenidate | 20 | 25.8 | 25.8 |
| Methylphenidate Hydrochloride | 39 | 25.4 | 25.5 |
| Atomoxetine Hydrochloride | 16 | 25.0 | 25.0 |
| Levodopa | 7 | 21.2 | 21.2 |
| Amphetamine | 4 | 17.6 | 17.6 |
| Rasagiline Mesylate | 5 | 16.4 | 16.4 |
| Lurasidone Hydrochloride | 8 | 14.0 | 14.0 |
| Brexpiprazole | 5 | 11.0 | 11.0 |